KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of TCRT
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Alaunos Therapeutics, Inc. stock price on Friday which ended trading at $1.32
(Updated on Apr 26, 2024)

Sell candidate since Apr 12, 2024 Loss -18.01% PDF

The Alaunos Therapeutics, Inc. stock price gained 13.79% on the last trading day (Friday, 26th Apr 2024), rising from $1.16 to $1.32. During the last trading day the stock fluctuated 18.11% from a day low at $1.13 to a day high of $1.34. The price has fallen in 8 of the last 10 days and is down by -18.01% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 42 thousand more shares were traded than the day before. In total, 51 thousand shares were bought and sold for approximately $67.24 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Due to the high volatility and the trend direction we are not able to give forecast range for this stock.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

TCRT Signals & Forecast

There are mixed signals in the stock today. The Alaunos Therapeutics, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.61. On a fall, the stock will find some support from the short-term average at $1.19. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Tuesday, February 06, 2024, and so far it has fallen -45.00%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Alaunos Therapeutics, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Alaunos Therapeutics, Inc. stock

Alaunos Therapeutics, Inc. finds support from accumulated volume at $1.29 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.206 between high and low, or 18.11%. For the last week, the stock has had daily average volatility of 16.30%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (TCRT) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Alaunos Therapeutics, Inc. to open at $1.26, and during the day (based on 14 day Average True Range), to move between $1.15 and $1.49, which gives a possible trading interval of +/-$0.165 (+/-12.54%) up or down from last closing price. If Alaunos Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 25.07% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.29 (2.27%) than the resistance at $1.40 (6.06%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Alaunos Therapeutics, Inc. stock A Buy?

Alaunos Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.045 Sell Candidate Unchanged

Predicted Opening Price for Alaunos Therapeutics, Inc. of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$1.26 ( 4.18%) $1.32

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TCRT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.47 11.39 %
R2 1.39 5.44 %
R1 1.34 1.77 %
Current price: 1.32
Support S1 1.19 -10.13 %
S2 1.14 -13.80 %
S3 1.06 -19.75 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.59 20.45 %
R2 1.54 16.67 %
R1 1.40 6.06 %
Current price 1.32
Support S1 1.29 -2.27%
S2 1.20 -9.09%
S3 1.12 -15.15%

FAQ

What is the symbol for Alaunos Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Alaunos Therapeutics, Inc. is TCRT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Alaunos Therapeutics, Inc. Stock?
Alaunos Therapeutics, Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Alaunos Therapeutics, Inc. Stock?
Alaunos Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Alaunos Therapeutics, Inc. Stock.

What's the current price of Alaunos Therapeutics, Inc. Stock?
As of the end of day on the Apr 26, 2024, the price of an Alaunos Therapeutics, Inc. (TCRT) share was $1.32.

What is the 52-week high and low for Alaunos Therapeutics, Inc. Stock?
The 52-week high for Alaunos Therapeutics, Inc. Stock is $2.60 and the 52-week low is $0.0441.

What is the market capitalization of Alaunos Therapeutics, Inc. Stock?
As of the Apr 26, 2024, the market capitalization of Alaunos Therapeutics, Inc. is 18.575M.

When is the next earnings date for Alaunos Therapeutics, Inc.?
The upcoming earnings date for Alaunos Therapeutics, Inc. is Aug 12, 2024.
Click to get the best stock tips daily for free!

About Alaunos Therapeutics, Inc.

Alaunos Therapeutics. Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers; hunTR, a human neoantigen T-cell receptor platform; and mbIL-15 to... TCRT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT